Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;23 Suppl 6(Suppl 6):e25591.
doi: 10.1002/jia2.25591.

HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project

Patrick S Sullivan  1 , Nancy Phaswana-Mafuya  2 , Stefan D Baral  3 , Rachel Valencia  1 , Ryan Zahn  1 , Karen Dominguez  1 , Clarence S Yah  4   5 , Jeb Jones  1 , Lesego B Kgatitswe  6 , A D McNaghten  1 , Aaron J Siegler  1 , Travis H Sanchez  1 , Linda-Gail Bekker  7
Affiliations

HIV prevalence and incidence in a cohort of South African men and transgender women who have sex with men: the Sibanye Methods for Prevention Packages Programme (MP3) project

Patrick S Sullivan et al. J Int AIDS Soc. 2020 Oct.

Abstract

Introduction: Men who have sex with men (MSM) and transgender women (TGW) are at increased risk for acquiring HIV, but there are limited HIV incidence data for these key populations in Africa. Understanding HIV prevalence and incidence provides important context for designing HIV prevention strategies, including pre-exposure prophylaxis (PrEP) programmes. We describe HIV prevalence, awareness of HIV infection, HIV incidence and associated factors for a cohort of MSM and TGW in Cape Town and Port Elizabeth, South Africa.

Methods: From 2015 to 2016, MSM and TGW in Cape Town and Port Elizabeth were enrolled and prospectively followed for 12 months, receiving a comprehensive package of HIV prevention services. HIV testing was conducted at baseline and at follow-up visits (targeted for three, six and twelve months). All HIV-negative PrEP-eligible participants were offered PrEP enrolment during the first four months of study participation. We determined HIV prevalence among participants at baseline, and incidence by repeat screening of initially HIV-negative participants with HIV tests at three, six and twelve months.

Results: Among 292 participants enrolled, HIV prevalence was high (43%; 95% CI: 38 to 49) and awareness of HIV status was low (50%). The 167 HIV-negative participants who were followed prospectively for 144.7 person-years; nine incident HIV infections were documented. Overall annual incidence was 6.2% (CI: 2.8 to 11.8) and did not differ by city. Annual HIV incidence was significantly higher for younger (18 to 19 years) MSM and TGW (MSM: 21.8% (CI: 1.2 to 100); TGW: 31.0 (CI: 3.7, 111.2)). About half of participants started PrEP during the study; the annual incidence of HIV among 82 (49%) PrEP starters was 3.6% (CI: 0.4, 13.1) and among those who did not start PrEP was 7.8% (CI: 3.1, 16.1).

Conclusions: HIV incidence was high among MSM and TGW in the context of receiving a comprehensive package of prevention interventions and offering of PrEP. PrEP uptake was high; the observed incidence of HIV in those who started PrEP was about half the incidence of HIV in those who did not. Future implementation-oriented studies should focus on decisions to start and continue PrEP for those at highest risk, including young MSM.

Keywords: HIV; HIV prevention; cohort studies; men who have sex with men; pre-exposure prophylaxis; sexually transmitted infections.

PubMed Disclaimer

Figures

Figure 1
Figure 1
HIV prevalence and awareness of HIV positivity by age among 237 MSM and transgender women, Cape Town and Port Elizabeth, South Africa, 2015 to 2016. MSM, men who have sex with men.
Figure 2
Figure 2
Participant timelines for nine participants who seroconverted for HIV during follow‐up, Cape Town and Port Elizabeth, 2015 to 2017.
See this image and copyright information in PMC

References

    1. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 2012;380(9839):367–77. - PMC - PubMed
    1. Poteat T, Ackerman B, Diouf D, Ceesay N, Mothopeng T, Odette K‐Z, et al. HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross‐sectional analysis. PLoS Medicine. 2017;14:e1002422. - PMC - PubMed
    1. Baral S, Rao A, Sullivan P, Phaswana‐Mafuya N, Diouf D, Millett G, et al. The disconnect between individual‐level and population‐level HIV prevention benefits of antiretroviral treatment. Lancet HIV. 2019;6(9):e632–8. - PubMed
    1. Sanders EJ, Okuku HS, Smith AD, Mwangome M, Wahome E, Fegan G, et al. High HIV‐1 incidence, correlates of HIV‐1 acquisition, and high viral loads following seroconversion among men who have sex with men in Coastal Kenya. AIDS. 2013;27(3):437–46. - PMC - PubMed
    1. Price MA, Rida W, Mwangome M, Mutua G, Middelkoop K, Roux S, et al. Identifying at‐risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth. J Acquir Immune Defic Syndr. 2012;59(2):185–93. - PubMed

Publication types

MeSH terms

Substances